On 3 February, Actions Semiconductor Co., Ltd. (NASDAQ:ACTS) reported Revenue for the fourth quarter of 2014 was $13.9 million, as compared to revenue of $13.1 million for the third quarter of 2014, and $17.6 million for the fourth quarter of 2013. Revenue for the year ended December 31, 2014 was $50.3 million, compared to $69.4 million for the year ended December 31, 2013. On Friday shares of Actions Semiconductor Co., Ltd. (NASDAQ:ACTS) closed at $1.54. Company’s sales growth for last 5 years was -6.10% and EPS growth for next 5 years is recorded as 25.00%.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at Leerink Global Healthcare Conference on Thursday, February 12, 2015 at 8:55 a.m. ET at the Waldorf Astoria Hotel in New York, NY. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) in last trading activity fell -2.35% to close at $10.82. Company weekly performance is -27.14% while its quarterly performance stands at 6.60%. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is -35.86% away from its 52 week high.
On 26 January, Chicopee Bancorp Inc. (NASDAQ:CBNK) reported net income of $299,000, or 6 cents per share, in its fourth quarter. The Chicopee, Massachusetts-based bank said it had earnings of 6 cents per share. The bank holding company posted revenue of $5.7 million in the period.On last trading day Chicopee Bancorp, Inc. (NASDAQ:CBNK) fell -0.55% to close at $16.40. Its volatility for the week is 2.40% while volatility for the month is 2.36%. CBNK’s sales growth for past 5 years was -0.90% and its EPS growth for past 5 years was 15.60%. Chicopee Bancorp, Inc. (NASDAQ:CBNK) monthly performance is -1.68%.
A Texas federal judge on 2 February refused to let two top executives of bankrupt Life Partners Holdings Inc. (NASDAQ:LPHI) get out of posting $8 million in bonds for their appeal of the U.S. Securities and Exchange Commission’s successful case against them and the life settlement company. Life Partners Holdings, Inc. (NASDAQ:LPHI) has 1.50% insider ownership while its institutional ownership stands at 8.60%. In last trading activity company’s stock closed at $0.19.
KYTHERA Biopharmaceuticals Inc. (NASDAQ:KYTH) has sought approval from Australia’s Therapeutic Goods Administration for ATX-101, an injectable treatment for the reduction of submental fat. On last trading day Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) fell -1.38% to close at $38.62. Its volatility for the week is 4.67% while volatility for the month is 4.76%. KYTH’s EPS growth for past 5 years was 28.60%. Kythera Biopharmaceuticals, Inc. (NASDAQ:KYTH) monthly performance is 10.47%.